Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-804-9 | CAS number: 99-96-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2.4 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 25
- Modified dose descriptor starting point:
- NOAEC
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2.4 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 25
- Modified dose descriptor starting point:
- NOAEC
Local effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 4.8 mg/m³
- Most sensitive endpoint:
- irritation (respiratory tract)
DNEL related information
- Overall assessment factor (AF):
- 12.5
- Dose descriptor:
- NOAEC
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 4.8 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 12.5
- Dose descriptor starting point:
- NOAEC
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 14.1 mg/kg bw/day
- Most sensitive endpoint:
- sensitisation (skin)
DNEL related information
- Overall assessment factor (AF):
- 50
- Modified dose descriptor starting point:
- NOAEL
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 8.6 mg/cm²
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 5
- Dose descriptor:
- other: NOAEL
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- high hazard (no threshold derived)
Additional information - workers
Summary of toxicological properties.
4-HBA is an organic acid. Those substances do not penetrate the intact skin in relevant amounts. This is also true with 4-HBA as the studies show.
A single dermal application of 2000 mg/kg bw. for 24 hours in an occlusive way to rabbits did not cause any mortality.
When 0,5 g 5-HBA were applied to 6 cm² skin of three female New-Zealand White rabbits only one mild local effect was seen with one animal. Exposure was 4 hours with observations at 1, 24, 48, 72 hours post exposure. The results showed a short term mild irritation in one animal. The limits for classification were not surpassed. Concluding, p-Hydroxybenzoic acid does not have to be classified as skin irritant according to CLP classification criteria.
Also a dermal sensitisation study with guinea pigs revealed no effects after the dermal application for 6 hours 3 times a week for 3 weeks. The guinea pigs received a dermal dosage of 0.2 cc = 0.282 g on an area of the skin of 6.45 cm² (43 mg/cm²). The animals weighed 290 to 400 g (Dose = 282 mg / 0.35 kg bw.; = 806 mg/kg bw.). No effects were observed.
Investigations with 24 hours dermal application of the radio-labelled compound to the skin of rats showed that only 4 % of the applied dosage were found in the body: 2% at the application site and 2 % in the body.
After oral administration of 5 g 4 -HBA every 6 hours up to a total dosage of 20 g to a human/humans. 70% were excreted unchanged with the urine. According to the authors this dosage is the maximum dosage that the human body is able to dispose of in the course of 24 hours (Power and Sherwin, 1927).
Oral dosages of 1.0 g/kg bodyweight were given to groups of 3 dogs. After administration of 4-HBA and Methylparaben (the methyl ester of 4 -HBA) the same concentrations of free 4 -HBA and the same kinetics for the elimination of 4 -HBA were found in the plasma (Jones et al., 1956).
After the oral administration of 4-HBA to dogs 94% of the dosage were recovered in the urine, 40.1% as free 4-HBA, 30.0% as glucuronic acid conjugate (Jones et al., 1956).
These data show that 4-HBA is resorbed relatively fast after oral dosages and it is relatively fast excreted with the urine. No accumulation was observed. Relevant parts of the resorbed substance were excreted unchanged.
Daily oral dosages of 0, 40, 200, and 1000 mg/kg bw. were administered by stomach tube to groups of 13 male rats for 42 days. In the same study 13 females per each of the dosage groups were treated also all in all between 38 to 52 days depending on the mating period. The test-article was formulated in 0.5%CMC and administered in 5 ml/kg bw..
At a dosis of 40 mg/kg bw. the animals showed no differences to the control animals (NOEL).
200 mg/kg bw. lead to salivation and abnormal respiratory sounds. The lymphocyte ratio and the platelet count were reduced.
1000 mg/kg bw. caused salivation, rhinorrhea, abnormal respiratory sounds, reduced body weight gain, white blood cell count, platelet count and total serum protein as well as increased segmented neutrophil ratio and increased activity of GPT, GOT and anorganic phosphorus in the serum, females: lung: inflammatory foci.
As summarised in the OECD SIDS (1999) a NOAEL of 1000 mg/kg bw./day was established: “4-Hydroxybenzoic acid induced rale and temporary salivation (sometimes accompanied by rhinorrhea) at 1,000 mg/kg and slightly at 200 mg/kg. These changes were suggesting the irritation of this chemical to respiratory tract. There were no adverse effects on body weight change and food consumption. At necropsy, no histological and morphological changes were observed. In hematological and blood chemical findings of males, decrease in the percentage of lymphocytes and the blood glucose at 200 mg/kg or more groups and decrease in total protein and increase in A/G ratio, GPT and GOT at 1,000 mg/kg were observed. These changes were significant, but not considered adverse effects. Therefore, NOAEL for systemic toxicity was considered to be 1000 mg/kg/day.”
An inhalation toxicity study was performed using 4 groups, one control and 3 dose groups, of 5 male and 5 female Sprague-Dawley rats each exposed to C-194, all in all 40 animals. The exposure period lasted for 6 hours per day for 5 days followed by another 5 day exposure period after an interruption of 2 days. The cumulative mean measured/nominal exposure concentrations were: 23.8, 64.0 and 189 mg/m³; 20, 60 and 200 mg/m3.
Physical examinations revealed increased instances of dried material around the facial area in all exposure groups.
20 mg/m³: no differences to the data of the control animals,
60 mg/m³: no differences to the data of the control animals,
200 mg/m³: The observed changes can be explained by an irritative effect of 4 -HBA to the eyes and in the respiratory tract specially in the nose and the lungs and a possible toxic effects on the liver and on the blood.
The local effect on mucous membranes was investigated in a study with rabbits. 0.1 g of 4-HBA was instilled as supplied into the eye of three New Zealand White rabbits. After 1hour the eyes were rinsed as the test item has not been removed. The ocular reactions observed during the study have been moderate to severe and partially reversible.
The chemosis remained in one animal in slight intensity until day 21 (last day of study). A corneal opacity remained in one animal until the last day of the study (day 21) with moderate intensity. A presence of a white spot on the lower eyelid and on the conjunctiva between maximal day 1 and maximal day 11 was observed in all three animals. Corneal neovascularisation was seen on day 14 and remaining on day 21 (last day of test, animal 3).
According to the rules of the EC regulation No 1272/2008 (OECD EU-GHS) 4-HBA has to be classified as: category 1 "irreversible effects on the eye".
These changes were suggesting the irritation of 4-HBA to the respiratory tract or to mucous membranes in general by direct application or inhalative exposure as well as after high oral dosages is the most critical effect of 4-HBA.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - General Population
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.